Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Common Equity (2016 - 2025)

Historic Common Equity for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $55.5 million.

  • InfuSystem Holdings' Common Equity fell 7.57% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year decrease of 7.57%. This contributed to the annual value of $57.5 million for FY2024, which is 999.39% up from last year.
  • InfuSystem Holdings' Common Equity amounted to $55.5 million in Q3 2025, which was down 7.57% from $54.5 million recorded in Q2 2025.
  • Over the past 5 years, InfuSystem Holdings' Common Equity peaked at $57.5 million during Q4 2024, and registered a low of $42.9 million during Q1 2021.
  • Moreover, its 5-year median value for Common Equity was $50.0 million (2023), whereas its average is $50.4 million.
  • Per our database at Business Quant, InfuSystem Holdings' Common Equity skyrocketed by 9504.54% in 2021 and then plummeted by 55.73% in 2022.
  • Over the past 5 years, InfuSystem Holdings' Common Equity (Quarter) stood at $48.3 million in 2021, then decreased by 0.56% to $48.0 million in 2022, then grew by 8.96% to $52.3 million in 2023, then rose by 9.99% to $57.5 million in 2024, then dropped by 3.58% to $55.5 million in 2025.
  • Its Common Equity stands at $55.5 million for Q3 2025, versus $54.5 million for Q2 2025 and $55.1 million for Q1 2025.